|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249.
2021.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Xia C, Dong X, Li H, Cao M, Sun D, He S,
Yang F, Yan X, Zhang S, Li N and Chen W: Cancer Statistics in China
and United States, 2022: Profiles, trends, and determinants. Chin
Med J (Engl). 135:584–590. 2022.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Chen YP, Chan ATC, Le QT, Blanchard P, Sun
Y and Ma J: Nasopharyngeal carcinoma. Lancet. 394:64–80.
2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Tang LL, Chen WQ, Xue WQ, He YQ, Zheng RS,
Zeng YX and Jia WH: Global trends in incidence and mortality of
nasopharyngeal carcinoma. Cancer Lett. 374:22–30. 2016.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Ribassin-Majed L, Marguet S, Lee AWM, Ng
WT, Ma J, Chan ATC, Huang PY, Zhu G, Chua DTT, Chen Y, et al: What
is the best treatment of locally advanced nasopharyngeal carcinoma?
An individual patient data network Meta-analysis. J Clin Oncol.
35:498–505. 2017.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Chen YP, Liu X, Zhou Q, Yang KY, Jin F,
Zhu XD, Shi M, Hu GQ, Hu WH, Sun Y, et al: Metronomic capecitabine
as adjuvant therapy in locoregionally advanced nasopharyngeal
carcinoma: A multicentre, open-label, parallel-group, randomised,
controlled, phase 3 trial. Lancet. 398:303–313. 2021.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Lin JC, Wang WY, Chen KY, Wei YH, Liang
WM, Jan JS and Jiang RS: Quantification of plasma Epstein-Barr
virus DNA in patients with advanced nasopharyngeal carcinoma. N
Engl J Med. 350:2461–2470. 2004.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Leung SF, Zee B, Ma BB, Hui EP, Mo F, Lai
M, Chan KC, Chan LY, Kwan WH, Lo YM and Chan AT: Plasma
Epstein-Barr viral deoxyribonucleic acid quantitation complements
tumor-node-metastasis staging prognostication in nasopharyngeal
carcinoma. J Clin Oncol. 24:5414–5418. 2006.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Zhou GQ, Tang LL, Mao YP, Chen L, Li WF,
Sun Y, Liu LZ, Li L, Lin AH and Ma J: Baseline serum lactate
dehydrogenase levels for patients treated with Intensity-modulated
radiotherapy for nasopharyngeal carcinoma: A predictor of poor
prognosis and subsequent liver metastasis. Int J Radiat.
82:e359–e365. 2012.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Mi S, Gong L and Sui Z: Friend or Foe? An
unrecognized role of uric acid in cancer development and the
potential anticancer effects of uric Acid-Lowering drugs. J Cancer.
11:5236–5244. 2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Wu L, Yang W, Zhang Y, Du X, Jin N, Chen
W, Li H, Zhang S and Xie B: Elevated serum uric acid is associated
with poor survival in advanced HCC patients and febuxostat improves
prognosis in HCC Rats. Front Pharmacol. 12(778890)2021.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Dai XY, He QS, Jing Z and Yuan JQ: Serum
uric acid levels and risk of kidney cancer incidence and mortality:
A prospective cohort study. Cancer Med. 9:5655–5661.
2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Feng Y, Fu M, Guan X, Wang C, Yuan F, Bai
Y, Meng H, Li G, Wei W, Li H, et al: Uric acid mediated the
association between BMI and postmenopausal breast cancer incidence:
A bidirectional mendelian randomization analysis and prospective
cohort study. Front Endocrinol (Lausanne).
12(742411)2021.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Becker BF: Towards the physiological
function of uric acid. Free Radic Biol Med. 14:615–631.
1993.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Mi N, Huang J, Huang C, Lin Y, He Q, Wang
H, Yang M, Lu Y, Lawer AL, Yue P, et al: High serum uric acid may
associate with the increased risk of colorectal cancer in females:
A prospective cohort study. Int J Cancer. 150:263–272.
2022.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Yiu A, Van Hemelrijck M, Garmo H, Holmberg
L, Malmström H, Lambe M, Hammar N, Walldius G, Jungner I,
Wulaningsih W, et al: Circulating uric acid levels and subsequent
development of cancer in 493,281 individuals: Findings from the
AMORIS Study. Oncotarget. 8:42332–42342. 2017.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Taghizadeh N, Vonk JM and Boezen HM: Serum
uric acid levels and cancer mortality risk among males in a large
general Population-based cohort study. Cancer Causes Control.
25:1075–1080. 2014.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Deng Z, Gu Y, Hou X, Zhang L, Bao Y, Hu C
and Jia W: Association between uric acid, cancer incidence and
mortality in patients with type 2 diabetes: Shanghai diabetes
registry study. Diabetes Metab Res Rev. 32:325–332. 2016.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Juraschek SP, Tunstall-Pedoe H and
Woodward M: Serum uric acid and the risk of mortality during 23
years follow-up in the Scottish Heart Health Extended Cohort Study.
Atherosclerosis. 233:623–629. 2014.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Kobylecki CJ, Afzal S and Nordestgaard BG:
Plasma urate, cancer incidence, and All-cause mortality: A
mendelian randomization study. Clin Chem. 63:1151–1160.
2017.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Kuo CF, Luo SF, See LC, Chou IJ, Fang YF
and Yu KH: Increased risk of cancer among gout patients: A
nationwide population study. J Bone Spine. 79:375–378.
2012.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Du XJ, Chen L, Li WF, Tang LL, Mao YP, Guo
R, Sun Y, Lin AH and Ma J: Use of pretreatment serum uric acid
level to predict metastasis in locally advanced nasopharyngeal
carcinoma. Head Neck. 39:492–497. 2017.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Hsueh CY, Shao M, Cao W, Li S and Zhou L:
Pretreatment serum uric acid as an efficient predictor of prognosis
in men with laryngeal squamous cell cancer: A retrospective cohort
study. Oxid Med Cell Longev. 2019(1821969)2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Fini MA, Elias A, Johnson RJ and Wright
RM: Contribution of uric acid to cancer risk, recurrence, and
mortality. Clin Transl Med. 1(16)2012.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Toyokuni S: Oxidative stress as an iceberg
in carcinogenesis and cancer biology. Arch Biochem Biophys.
595:46–49. 2016.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Kim AW, Batus M, Myint R, Fidler MJ, Basu
S, Bonomi P, Faber LP, Wightman SC, Warren WH, McIntire M, et al:
Prognostic value of xanthine oxidoreductase expression in patients
with non-small cell lung cancer. Lung Cancer. 71:186–190.
2011.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Selcukbiricik F, Kanbay M, Solak Y, Bilici
A, Kanıtez M, Balık E and Mandel NM: Serum uric acid as a surrogate
marker of favorable response to bevacizumab treatment in patients
with metastatic colon cancer. Clin Transl Oncol. 18:1082–1087.
2016.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Song Y, Tang L, Han J, Gao Y, Tang B, Shao
M, Yuan W, Ge W, Huang X, Yao T, et al: Uric acid provides
protective role in red blood cells by antioxidant defense: A
hypothetical analysis. Oxid Med Cell Longev.
2019(3435174)2019.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Black CN, Bot M, Scheffer PG, Snieder H
and Penninx B: Uric acid in major depressive and anxiety disorders.
J Affect Disord. 225:684–690. 2018.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Ames BN, Cathcart R, Schwiers E and
Hochstein P: Uric acid provides an antioxidant defense in humans
against oxidant- and radical-caused aging and cancer: A hypothesis.
Proc Natl Acad Sci USA. 78:6858–6862. 1981.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Dziaman T, Banaszkiewicz Z, Roszkowski K,
Gackowski D, Wisniewska E, Rozalski R, Foksinski M, Siomek A,
Speina E, Winczura A, et al: 8-Oxo-7,8-dihydroguanine and uric acid
as efficient predictors of survival in colon cancer patients. Int J
Cancer. 134:376–383. 2014.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Brook I: Early side effects of radiation
treatment for head and neck cancer. Cancer Radiother. 25:507–513.
2021.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Dasari S and Tchounwou PB: Cisplatin in
cancer therapy: Molecular mechanisms of action. Eur J Pharmacol.
740:364–378. 2014.PubMed/NCBI View Article : Google Scholar
|
